Event JSON
{
"id": "1993f485e1a3b4102d8929117436eaa68e7d9a6c175ec86af86564789b68f740",
"pubkey": "f1b8cad8814a5e98cdaadb1f883c7a08cd72a3e1091552c7ea5bd784b802001b",
"created_at": 1732757564,
"kind": 1,
"tags": [
[
"r",
"https://www.bbc.com/news/articles/cev93777g79o"
],
[
"subject",
"First new asthma attack treatment in 50 years"
],
[
"published_at",
"1732757220"
],
[
"image",
"https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/3cdf/live/e8597b30-acd3-11ef-92c5-85d8a8f7d550.jpg"
],
[
"p",
"f1b8cad8814a5e98cdaadb1f883c7a08cd72a3e1091552c7ea5bd784b802001b",
"wss://articles.layer3.news"
],
[
"imeta",
"url https://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/3cdf/live/e8597b30-acd3-11ef-92c5-85d8a8f7d550.jpg"
],
[
"t",
"mainstream:perspective"
],
[
"summary",
"The new treatment, called benralizumab, targets a type of white blood cell called eosinophils that can cause inflammation and damage in the lungs. The study, which involved 158 patients, found that treatment with benralizumab was more effective than steroids in controlling asthma attacks, with a treatment failure rate of 45% compared to 74% for steroids. The results also showed that patients treated with benralizumab were less likely to be admitted to hospital, need another round of treatment, or die. The researchers believe that this could revolutionize the treatment of asthma and COPD, and could benefit a huge number of people."
]
],
"content": "nostr:nprofile1qyd8wumn8ghj7ctjw35kxmr9wvhxcctev4erxtnwv4mhxqpq7xuv4kypff0f3nd2mv0cs0r6prxh9glppy2493l2t0tcfwqzqqdsl58psn\nhttps://ichef.bbci.co.uk/ace/standard/240/cpsprodpb/3cdf/live/e8597b30-acd3-11ef-92c5-85d8a8f7d550.jpg\nAround two million asthma and COPD attacks each year could be treated with the drug, a study suggests.\nhttps://www.bbc.com/news/articles/cev93777g79o",
"sig": "7dc2a70d211c7d7f77c5d60bb039a1f58c1f76a719a40484db331307153770e7db9544e4090b42e0f76bd55ed7991716c43dd553b243a672b1f814c458704b5e"
}
